These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 15359582)

  • 1. Evaluating barriers to bioavailability in vivo: validation of a technique for separately assessing gastrointestinal absorption and hepatic extraction.
    Letendre L; Scott M; Dobson G; Hidalgo I; Aungst B
    Pharm Res; 2004 Aug; 21(8):1457-62. PubMed ID: 15359582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo determination of drug kinetic linearity and individual organ elimination by the accelerated infusion technique.
    Li J; Dobson GL; Marietta MP; Rhodes GR; Hidalgo IJ
    J Pharmacol Toxicol Methods; 1997 Feb; 37(1):47-53. PubMed ID: 9086288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous blood withdrawal as a rapid screening method for determining clearance of oral bioavailability in rats.
    Humphreys WG; Obermeier MT; Morrison RA
    Pharm Res; 1998 Aug; 15(8):1257-61. PubMed ID: 9706058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation of gut and hepatic first-pass effect of drugs: 1. Studies of verapamil in ported dogs.
    Lee YH; Perry BA; Lee HS; Kunta JR; Sutyak JP; Sinko PJ
    Pharm Res; 2001 Dec; 18(12):1721-8. PubMed ID: 11785692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The increased intestinal absorption rate is responsible for the reduced hepatic first-pass extraction of propranolol in rats with cisplatin-induced renal dysfunction.
    Okabe H; Mizukami A; Taguchi M; Aiba T; Yasuhara M; Hashimoto Y
    J Pharm Pharmacol; 2003 Apr; 55(4):479-86. PubMed ID: 12803769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic and gastrointestinal first-pass effects of vitexin-4″-O-glucoside in rats.
    Chen Y; Zhang W; Li D; Ai J; Meng Y; Ying X; Kang T
    J Pharm Pharmacol; 2013 Oct; 65(10):1500-7. PubMed ID: 24028617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of aging on the pharmcokinetics of atenolol, metoprolol and propranolol in the rat.
    Belpaire FM; de Smet F; Vynckier LJ; Vermeulen AM; Rosseel MT; Bogaert MG; Chauvelot-Moachon L
    J Pharmacol Exp Ther; 1990 Jul; 254(1):116-22. PubMed ID: 2366179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of the plasma concentration profiles of orally administered drugs in rats on the basis of gastrointestinal transit kinetics and absorbability.
    Sawamoto T; Haruta S; Kurosaki Y; Higaki K; Kimura T
    J Pharm Pharmacol; 1997 Apr; 49(4):450-7. PubMed ID: 9232547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucosamine modulates propranolol pharmacokinetics via intestinal permeability in rats.
    Al Shaker HA; Qinna NA; Badr M; Al Omari MMH; Idkaidek N; Matalka KZ; Badwan AA
    Eur J Pharm Sci; 2017 Jul; 105():137-143. PubMed ID: 28502673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Site of drug absorption after oral administration: assessment of membrane permeability and luminal concentration of drugs in each segment of gastrointestinal tract.
    Masaoka Y; Tanaka Y; Kataoka M; Sakuma S; Yamashita S
    Eur J Pharm Sci; 2006 Nov; 29(3-4):240-50. PubMed ID: 16876987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of turpentine-induced inflammation on the disposition kinetics of propranolol, metoprolol, and antipyrine in the rat.
    Belpaire FM; de Smet F; Chindavijak B; Fraeyman N; Bogaert MG
    Fundam Clin Pharmacol; 1989; 3(2):79-88. PubMed ID: 2722116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mathematical modeling of oral absorption and bioavailability of a fluoroquinolone after its precipitation in the gastrointestinal tract.
    Fernandez-Teruel C; Mangas-Sanjuan V; Gonzalez-Alvarez I; Ruiz-Garcia A; Casabó VG; Bermejo M
    Xenobiotica; 2013 Sep; 43(9):745-54. PubMed ID: 23294363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ion-trapping, microsomal binding, and unbound drug distribution in the hepatic retention of basic drugs.
    Siebert GA; Hung DY; Chang P; Roberts MS
    J Pharmacol Exp Ther; 2004 Jan; 308(1):228-35. PubMed ID: 14566005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of in vivo hepatic extraction ratio from in vitro metabolism by rat hepatocytes.
    Singh K; Tripp SL; Dunton AW; Douglas FL; Rakhit A
    Drug Metab Dispos; 1991; 19(5):990-6. PubMed ID: 1686248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonlinear first-pass metabolism of propranolol in the rat.
    Suzuki T; Ohkuma T; Isozaki S
    J Pharmacobiodyn; 1981 Feb; 4(2):131-41. PubMed ID: 7277199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel simultaneous modeling approach to estimate linearity of pharmacokinetic parameters, including saturation of intestinal efflux, in the rat.
    Williams JA; Sahasrabudhe V; Walton J; Zhu T; Hudson G; Koup JR
    J Pharmacol Toxicol Methods; 2005; 52(3):307-13. PubMed ID: 15979348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal absorption and hepatic extraction of propranolol and metoprolol in rats with bilateral ureteral ligation.
    Okabe H; Higashi T; Ohta T; Hashimoto Y
    Biol Pharm Bull; 2004 Sep; 27(9):1422-7. PubMed ID: 15340230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An in vitro digestion test that reflects rat intestinal conditions to probe the importance of formulation digestion vs first pass metabolism in Danazol bioavailability from lipid based formulations.
    Anby MU; Nguyen TH; Yeap YY; Feeney OM; Williams HD; Benameur H; Pouton CW; Porter CJ
    Mol Pharm; 2014 Nov; 11(11):4069-83. PubMed ID: 25265395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous evaluation of intestinal absorption and hepatic extraction of 5-fluorouracil using portal-systemic concentration difference by short-period double dosing in a single conscious rat.
    Sawai Y; Yamaoka K; Ito T; Nakagawa T
    Biol Pharm Bull; 1997 Dec; 20(12):1313-6. PubMed ID: 9448112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High body clearance and low oral bioavailability of alantolactone, isolated from Inula helenium, in rats: extensive hepatic metabolism and low stability in gastrointestinal fluids.
    Lee JY; Kim SB; Chun J; Song KH; Kim YS; Chung SJ; Cho HJ; Yoon IS; Kim DD
    Biopharm Drug Dispos; 2016 Apr; 37(3):156-67. PubMed ID: 26861967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.